(AXON) Axon Enterprise - Overview
Sector: Industrials | Industry: Aerospace & Defense | Exchange: NASDAQ (USA) | Market Cap: 34.566m USD | Total Return: -19.3% in 12m
Avg Trading Vol: 395M USD
Peers RS (IBD): 7.3
EPS Trend: 36.2%
Qual. Beats: 0
Rev. Trend: 99.8%
Qual. Beats: 1
P/E ratio: 286.6267
Technicals: volatileAxon Enterprise Inc. (AXON) is a technology company providing public safety solutions globally. Its business model is bifurcated into Software and Services, and Connected Devices segments.
The Software and Services segment delivers cloud-based software-as-a-service (SaaS) for digital evidence management. SaaS models typically involve recurring revenue streams, offering stability. Key products include Axon Evidence and Axon Records.
The Connected Devices segment focuses on integrated hardware, including TASER-brand conducted energy devices, body cameras, and drone technology. The public safety technology sector is characterized by substantial government procurement processes and long sales cycles.
Axon serves a diverse client base, including international, federal, state, and local government agencies, commercial enterprises, and consumers. Distribution occurs via direct sales, partners, and resellers. Investors seeking detailed financial metrics and growth projections should continue their research on ValueRay.
- Subscription growth drives Software and Services segment revenue
- TASER device sales impact Connected Devices segment performance
- Government contract awards secure future revenue streams
- Cloud infrastructure costs affect profitability
- Regulatory scrutiny of law enforcement technology poses risk
| Net Income: 124.9m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.01 > 0.02 and ΔFCF/TA -6.29 > 1.0 |
| NWC/Revenue: 80.69% < 20% (prev 29.75%; Δ 50.94% < -1%) |
| CFO/TA 0.03 > 3% & CFO 211.3m > Net Income 124.9m |
| Net Debt (708.5m) to EBITDA (262.7m): 2.70 < 3 |
| Current Ratio: 2.53 > 1.5 & < 3 |
| Outstanding Shares: last quarter (100.0m) vs 12m ago 23.32% < -2% |
| Gross Margin: 59.66% > 18% (prev 0.60%; Δ 5.91k% > 0.5%) |
| Asset Turnover: 48.45% > 50% (prev 46.54%; Δ 1.90% > 0%) |
| Interest Coverage Ratio: 1.96 > 6 (EBITDA TTM 262.7m / Interest Expense TTM 94.2m) |
| A: 0.32 (Total Current Assets 3.71b - Total Current Liabilities 1.47b) / Total Assets 7.00b |
| B: 0.13 (Retained Earnings 936.7m / Total Assets 7.00b) |
| C: 0.03 (EBIT TTM 184.4m / Avg Total Assets 5.74b) |
| D: 0.25 (Book Value of Equity 924.9m / Total Liabilities 3.76b) |
| Altman-Z'' Score: 3.01 = A |
| DSRI: 0.78 (Receivables 955.7m/915.5m, Revenue 2.78b/2.08b) |
| GMI: 1.00 (GM 59.66% / 59.61%) |
| AQI: 0.98 (AQ_t 0.42 / AQ_t-1 0.43) |
| SGI: 1.33 (Revenue 2.78b / 2.08b) |
| TATA: -0.01 (NI 124.9m - CFO 211.3m) / TA 7.00b) |
| Beneish M-Score: -2.99 (Cap -4..+1) = A |
Over the past week, the price has changed by -6.99%, over one month by -25.76%, over three months by -25.22% and over the past year by -19.25%.
- StrongBuy: 7
- Buy: 7
- Hold: 3
- Sell: 0
- StrongSell: 0
| ISSUER | TARGET | UP/DOWN |
|---|---|---|
| Wallstreet Target Price | 735 | 73.1% |
| Analysts Target Price | 735 | 73.1% |
P/E Forward = 66.6667
P/S = 12.436
P/B = 12.3044
P/EG = 1.6448
Revenue TTM = 2.78b USD
EBIT TTM = 184.4m USD
EBITDA TTM = 262.7m USD
Long Term Debt = 1.73b USD (from longTermDebt, last quarter)
Short Term Debt = 80.6m USD (from shortTermDebt, last quarter)
Debt = 1.91b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 708.5m USD (from netDebt column, last quarter)
Enterprise Value = 34.77b USD (34.57b + Debt 1.91b - CCE 1.71b)
Interest Coverage Ratio = 1.96 (Ebit TTM 184.4m / Interest Expense TTM 94.2m)
EV/FCF = 463.1x (Enterprise Value 34.77b / FCF TTM 75.1m)
FCF Yield = 0.22% (FCF TTM 75.1m / Enterprise Value 34.77b)
FCF Margin = 2.70% (FCF TTM 75.1m / Revenue TTM 2.78b)
Net Margin = 4.49% (Net Income TTM 124.9m / Revenue TTM 2.78b)
Gross Margin = 59.66% ((Revenue TTM 2.78b - Cost of Revenue TTM 1.12b) / Revenue TTM)
Gross Margin QoQ = 57.90% (prev 60.14%)
Tobins Q-Ratio = 4.97 (Enterprise Value 34.77b / Total Assets 7.00b)
Interest Expense / Debt = 1.51% (Interest Expense 28.8m / Debt 1.91b)
Taxrate = 40.00% (2.00m / 5.00m)
NOPAT = 110.7m (EBIT 184.4m * (1 - 40.00%))
Current Ratio = 2.53 (Total Current Assets 3.71b / Total Current Liabilities 1.47b)
Debt / Equity = 0.59 (Debt 1.91b / totalStockholderEquity, last quarter 3.24b)
Debt / EBITDA = 2.70 (Net Debt 708.5m / EBITDA 262.7m)
Debt / FCF = 9.44 (Net Debt 708.5m / FCF TTM 75.1m)
Total Stockholder Equity = 2.89b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.18% (Net Income 124.9m / Total Assets 7.00b)
RoE = 4.32% (Net Income TTM 124.9m / Total Stockholder Equity 2.89b)
RoCE = 3.99% (EBIT 184.4m / Capital Employed (Equity 2.89b + L.T.Debt 1.73b))
RoIC = 2.28% (NOPAT 110.7m / Invested Capital 4.85b)
WACC = 8.67% (E(34.57b)/V(36.48b) * Re(9.10%) + D(1.91b)/V(36.48b) * Rd(1.51%) * (1-Tc(0.40)))
Discount Rate = 9.10% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 14.57%
[DCF] Terminal Value 79.43% ; FCFF base≈176.9m ; Y1≈218.2m ; Y5≈372.2m
[DCF] Fair Price = 61.05 (EV 5.62b - Net Debt 708.5m = Equity 4.91b / Shares 80.4m; r=8.67% [WACC]; 5y FCF grow 25.0% → 3.0% )
EPS Correlation: 36.24 | EPS CAGR: -34.46% | SUE: -4.0 | # QB: 0
Revenue Correlation: 99.81 | Revenue CAGR: 35.30% | SUE: 4.0 | # QB: 1
EPS next Quarter (2026-06-30): EPS=1.81 | Chg7d=+0.000 | Chg30d=+0.030 | Revisions Net=+0 | Analysts=18
EPS current Year (2026-12-31): EPS=7.79 | Chg7d=+0.000 | Chg30d=+0.216 | Revisions Net=+9 | Growth EPS=+13.7% | Growth Revenue=+29.1%
EPS next Year (2027-12-31): EPS=10.57 | Chg7d=+0.000 | Chg30d=+0.801 | Revisions Net=+11 | Growth EPS=+35.8% | Growth Revenue=+29.1%
[Analyst] Revisions Ratio: +0.00 (7 Up / 7 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 8.8% (Discount Rate 9.1% - Earnings Yield 0.3%)
[Growth] Growth Spread = +20.1% (Analyst 28.9% - Implied 8.8%)